TAM
OKUR

Tucker Asset Management’s OnKure Therapeutics OKUR Stock Holding History

Tucker Asset Management’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,675
Closed -$241K – 1580
2023
Q2 		$241K Buy
+3,675
New +$296K 0.07% 91

Other funds holding OKUR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tucker Asset Management's OKUR Position: Q3 2023 in Review

Tucker Asset Management sold out of OnKure Therapeutics (OKUR) in Q3 2023, closing a stake of 3,675 shares — an estimated $241K sold.

Tucker Asset Management first reported a position in OKUR in Q2 2023 and held it in 1 quarter. The position peaked at $241K in Q2 2023. 58 funds tracked by Wall St. Rank hold OKUR as of Q3 2023.

  • Tucker Asset Management reported no remaining OnKure Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Tucker Asset Management sold 3,675 OnKure Therapeutics shares in Q3 2023, an estimated $241K.
  • Tucker Asset Management first reported a position in OnKure Therapeutics in Q2 2023 and held it in 1 quarter.
  • Tucker Asset Management's OnKure Therapeutics position peaked at $241K in Q2 2023.
  • 58 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q3 2023.

Based on Tucker Asset Management's 13F filing for Q3 2023, filed 4 Dec 2023.